d1000 Varejo Farma Participações Management
Management criteria checks 0/4
We currently do not have sufficient information about the CEO.
Key information
Sammy Birmarcker
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | no data |
| CEO ownership | n/a |
| Management average tenure | no data |
| Board average tenure | no data |
Recent management updates
No updates
Recent updates
Is d1000 Varejo Farma Participações (BVMF:DMVF3) A Risky Investment?
Nov 27
d1000 Varejo Farma Participações S.A.'s (BVMF:DMVF3) Share Price Matching Investor Opinion
Oct 15d1000 Varejo Farma Participações S.A.'s (BVMF:DMVF3) Popularity With Investors Is Clear
Apr 19Returns Are Gaining Momentum At d1000 Varejo Farma Participações (BVMF:DMVF3)
Oct 31d1000 Varejo Farma Participações (BVMF:DMVF3) Shareholders Will Want The ROCE Trajectory To Continue
Jul 13Earnings Not Telling The Story For d1000 Varejo Farma Participações S.A. (BVMF:DMVF3)
May 13Investors Shouldn't Be Too Comfortable With d1000 Varejo Farma Participações' (BVMF:DMVF3) Robust Earnings
Aug 18d1000 Varejo Farma Participações (BVMF:DMVF3) Shareholders Will Want The ROCE Trajectory To Continue
Oct 29CEO
Sammy Birmarcker
no data
Tenure
Mr. Sammy Birmarcker serves as the Chief Executive Officer, President and Member of Board of Executive Officers at Profarma Distribuidora de Produtos Farmacêuticos S.A. and has been its Director since 2006...
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/18 14:43 |
| End of Day Share Price | 2024/12/18 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
d1000 Varejo Farma Participações S.A. is covered by 3 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Georgia Jorge | BB Banco de Investimento S.A. |
| Mariana Ferraz Costa Zanini | Eleven Financial Research |
| Jennie Li | XP Investimentos |